PDS Biotech prices up to USD 22.55 million PIPE led by Nant Capital - PDSB News | RalliesPDS Biotech prices up to USD 22.55 million PIPE led by Nant Capital
P
PDSB• PDS Biotech prices PIPE financing led by Nant Capital
- PDS Biotech announced a PIPE financing of up to USD 22.55 million led by Nant Capital, with additional participation from existing investors.
- Initial closing targets about USD 11.55 million around Sept. 11, 2026, via unregistered common stock or pre-funded warrants with common warrants.
- Units priced at USD 0.28 per share unit or USD 0.28 per pre-funded unit.
- Milestone closing would add USD 11 million if a registrational Phase 3 PDS0301 protocol is submitted to the FDA in collaboration with Nant.
- Nant can appoint two directors if it owns at least 15%, including Patrick Soon-Shiong; proceeds earmarked for debt repayment, R&D, working capital.
CSTL
•
